Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 30, Issue 1, Pages 15-25
Publisher
Informa UK Limited
Online
2019-12-18
DOI
10.1080/13543776.2020.1704733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials
- (2019) Olivier Mir et al. CLINICAL CANCER RESEARCH
- Causes, consequences, and therapy of tumors acidosis
- (2019) Smitha R. Pillai et al. CANCER AND METASTASIS REVIEWS
- Targeting acidity in cancer and diabetes
- (2019) Robert J. Gillies et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Rethinking Our Approach of Combining Novel Agents With Standard Chemotherapy in Small Cell Lung Cancer
- (2019) Shun Lu et al. Journal of Thoracic Oncology
- Rethinking Alkylating(-Like) Agents for Solid Tumor Management
- (2019) Hélène Lajous et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
- (2019) Giovanni Bruno et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Proton pump inhibitors reduce breast cancer risk in gastric ulcer patients: A population‐based cohort study
- (2019) Dah‐Ching Ding et al. Breast Journal
- A drug–drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics
- (2019) Jianke Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review
- (2019) Stephanie E. Pearson et al. INTERNATIONAL JOURNAL OF AUDIOLOGY
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical efficacy of weekly cisplatin for treatment of patients with breast cancer
- (2019) Ying Ma et al. MEDICINE
- Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis
- (2019) P Laoveeravat et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer
- (2019) Yunpeng Yang et al. Journal of Thoracic Disease
- Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
- (2019) Yu-Hung Fang et al. Cancer Management and Research
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer
- (2019) Nele Brusselaers et al. Cancer Epidemiology
- Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo
- (2019) Zhen-Ning Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma
- (2018) Olga Kuchuk et al. OncoImmunology
- Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study
- (2018) Chao-Hung Chen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- 25 Years of Proton Pump Inhibitors: A Comprehensive Review
- (2017) Daniel S. Strand et al. Gut and Liver
- Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
- (2017) Guillem Pascual-Pasto et al. JOURNAL OF CONTROLLED RELEASE
- Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice
- (2017) Simonetta Astigiano et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The high price of anticancer drugs: origins, implications, barriers, solutions
- (2017) Vinay Prasad et al. Nature Reviews Clinical Oncology
- National trends in use and costs of oral anticancer drugs in France: An 8-year population-based study
- (2017) Pauline Bosco-Lévy et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Proton pump inhibition and cancer therapeutics: A specific tumor targeting or it is a phenomenon secondary to a systemic buffering?
- (2017) Enrico Spugnini et al. SEMINARS IN CANCER BIOLOGY
- Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
- (2017) Kenji Ikemura et al. Frontiers in Pharmacology
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma
- (2016) Andrea Canitano et al. CANCER LETTERS
- Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial
- (2016) Paolo Marchetti et al. Clinical Colorectal Cancer
- High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art
- (2016) Rosa Falcone et al. DIGESTIVE AND LIVER DISEASE
- An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network
- (2016) Henry C. Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity
- (2016) Shreesh Ojha et al. Oxidative Medicine and Cellular Longevity
- Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance
- (2016) Sofia Avnet et al. Oncotarget
- In vivo and in vitro protective effects of omeprazole against neuropathic pain
- (2016) Sanjay K. Chanchal et al. Scientific Reports
- Effect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL Mice
- (2016) Tommaso Azzarito et al. PLoS One
- Proton channels and exchangers in cancer
- (2015) Enrico Pierluigi Spugnini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy
- (2015) Q Tan et al. BRITISH JOURNAL OF CANCER
- Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma
- (2015) Tommaso Azzarito et al. CANCER LETTERS
- Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer
- (2015) L. S. Schneider et al. CANCER RESEARCH
- Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
- (2015) Man Yu et al. CANCER SCIENCE
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- Proton pump inhibitors for the treatment of cancer in companion animals
- (2015) Megan Walsh et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
- (2015) Bi-Yun Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Evidence-based support for the use of proton pump inhibitors in cancer therapy
- (2015) Stefano Fais Journal of Translational Medicine
- Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics
- (2015) Anja Wilmes et al. TOXICOLOGY IN VITRO
- Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
- (2015) Yoo-Young Lee et al. Oncotarget
- Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion
- (2014) Shangrong Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
- (2014) Stefano Fais et al. CANCER AND METASTASIS REVIEWS
- Proton Pump Inhibitors and Histamine 2 Blockers Are Associated with Improved Overall Survival in Patients with Head and Neck Squamous Carcinoma
- (2014) S. Papagerakis et al. Cancer Prevention Research
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
- (2014) Joong Sup Shim et al. International Journal of Biological Sciences
- A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin
- (2014) Irene Brana et al. INVESTIGATIONAL NEW DRUGS
- High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors
- (2014) Enrico P Spugnini et al. Journal of Translational Medicine
- V-ATPase Inhibition Regulates Anoikis Resistance and Metastasis of Cancer Cells
- (2014) C. M. Schempp et al. MOLECULAR CANCER THERAPEUTICS
- The Economic Burden of Head and Neck Cancer: A Systematic Literature Review
- (2014) Erika Wissinger et al. PHARMACOECONOMICS
- Use of the Proton Pump Inhibitor Pantoprazole to Modify the Distribution and Activity of Doxorubicin: A Potential Strategy to Improve the Therapy of Solid Tumors
- (2013) K. J. Patel et al. CLINICAL CANCER RESEARCH
- Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3
- (2013) Tomohiko Kurata et al. Drug Metabolism and Pharmacokinetics
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
- (2013) Stefano Ferrari et al. Journal of Translational Medicine
- Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development
- (2013) Gillian S. Smelick et al. MOLECULAR PHARMACEUTICS
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo
- (2012) Min Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump
- (2012) S Fan et al. ONCOGENE
- Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole
- (2011) Naveen Kumar Vishvakarma et al. BIOCHIMIE
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors
- (2011) Enrico P Spugnini et al. Journal of Translational Medicine
- Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages
- (2010) Naveen Kumar Vishvakarma et al. IMMUNOLOGY LETTERS
- pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
- (2009) Angelo De Milito et al. INTERNATIONAL JOURNAL OF CANCER
- Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs
- (2009) Peter B. Bach NEW ENGLAND JOURNAL OF MEDICINE
- Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy
- (2008) Kunihiro Suzuki et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
- Drug Target Identification Using Side-Effect Similarity
- (2008) M. Campillos et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now